Primary fallopian tube carcinoma arising in the setting of chronic pelvic inflammatory disease

Case Reports in Medicine

Volumn 2014, Issue , 2014, Pages

  Zardawi, Ibrahim M ^a  

^a PORT MACQUARIE BASE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CD103 ANTIGEN; ESTROGEN RECEPTOR; VIMENTIN;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CASE REPORT; CHLAMYDIA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOMETRIOID CARCINOMA; FEMALE; FOLLOW UP; GONORRHEA; HUMAN; HYPERTENSION; LAPAROTOMY; METRORRHAGIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PELVIC INFLAMMATORY DISEASE; PERITONEAL BIOPSY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SEPSIS; TISSUE ADHESION; TUBOOVARIAN ABSCESS; TUMOR INVASION; UTERINE TUBE CARCINOMA;

EID: 84940873782     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2014/645045     Document Type: Article

References (25)

1. Riskai A., Leminen A., Pukkala E., Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953-97. International Journal of Cancer 2003 104 5 643 645 2-s2.0-0037400980 10.1002/ijc.10970 (Pubitemid 36337266)
2. Pectasides D., Pectasides E., Economopoulos T., Fallopian tube carcinoma: a review. The Oncologist 2006 11 8 902 912 2-s2.0-33748576916 10.1634/theoncologist.11-8-902 (Pubitemid 44373763)
3. Lau H. Y., Chen Y. J., Yen M. S., Chen R. F., Yeh S. O., Twu N. F., Primary fallopian tube carcinoma: a clinicopathologic analysis and literature review. Journal of the Chinese Medical Association 2013 76 10 583 587 10.1016/j.jcma.2013.06.010
4. Riska A., Sund R., Pukkala E., Gissler M., Leminen A., Parity, tubal sterilization, hysterectomy and risk of primary fallopian tube carcinoma in Finland, 1975-2004. International Journal of Cancer 2007 120 6 1351 1354 2-s2.0-33847021873 10.1002/ijc.22491
5. Vicus D., Finch A., Rosen B., Fan I., Bradley L., Cass I., Sun P., Karlan B., McLaughlin J., Narod S. A., Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation. Gynecologic Oncology 2010 118 2 155 159 2-s2.0-77954243290 10.1016/j.ygyno.2010.03.009
6. Jordan S. J., Green A. C., Whiteman D. C., Moore S. P., Bain C. J., Gertig D. M., Webb P. M., Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis. International Journal of Cancer 2008 122 7 1598 1603 2-s2.0-39649096555 10.1002/ijc.23287 (Pubitemid 351294969)
7. Riska A., Martinsen J. I., Kjaerheim K., Lynge E., Sparen P., Tryggvadottir L., Weiderpass E., Pukkala E., Occupation and risk of primary Fallopian tube carcinoma in Nordic countries. International Journal of Cancer 2012 131 1 186 192 2-s2.0-84860221255 10.1002/ijc.26337
8. Australian Bureau of Statistics, Australian demographic statistics. Cat. 2011 No. 3101.0
9. Madeleine M. M., Anttila T., Schwartz S. M., Saikku P., Leinonen M., Carter J. J., Wurscher M., Johnson L. G., Galloway D. A., Daling J. R., Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. International Journal of Cancer 2007 120 3 650 655 2-s2.0-33845690265 10.1002/ijc.22325 (Pubitemid 44969037)
10. Ponzoni M., Ferreri A. J. M., Guidoboni M., Lettini A. A., Cangi M. G., Pasini E., Sacchi L., Pecciarini L., Grassi S., Cin E. D., Stefano R., Magnino S., Dolcetti R., Doglioni C., Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods. Clinical Cancer Research 2008 14 18 5794 5800 2-s2.0-53249125191 10.1158/1078-0432.CCR-08-0676
11. Tavassoli F. A., Devilee P., WHO Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs 2003 Lyon, France IARC Press
12. Dubeau L., Drapkin R., Coming into focus: the non-ovarian origins of ovarian cancer. Annals of Oncology 2013 24, supplement 8 viii28 viii35 10.1093/annonc/mdt308
13. Kindelberger D. W., Lee Y., Miron A., Hirsch M. S., Feltmate C., Medeiros F., Callahan M. J., Garner E. O., Gordon R. W., Birch C., Berkowitz R. S., Muto M. G., Crum C. P., Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. The American Journal of Surgical Pathology 2007 31 2 161 169 2-s2.0-33846624310 10.1097/01.pas.0000213335.40358. 47 (Pubitemid 46175016)
14. Lee Y., Medeiros F., Kindelberger D., Callahan M. J., Muto M. G., Crum C. P., Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer. Advances in Anatomic Pathology 2006 13 1 1 7 2-s2.0-33644936023 10.1097/01.pap.0000201826.46978.e5 (Pubitemid 44357143)
15. Medeiros F., Muto M. G., Lee Y., Elvin J. A., Callahan M. J., Feltmate C., Garber J. E., Cramer D. W., Crum C. P., The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. The American Journal of Surgical Pathology 2006 30 2 230 236 2-s2.0-33645225423 10.1097/01.pas.0000180854.28831.77 (Pubitemid 43740193)
16. Kurman R. J., Vang R., Junge J., Hannibal C. G., Kjaer S. K., Shih I.-M., Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis. The American Journal of Surgical Pathology 2011 35 11 1605 1614 2-s2.0-80054988602 10.1097/PAS.0b013e318229449f
17. Hold G. L., El-Omar E. M., Genetic aspects of inflammation and cancer. Biochemical Journal 2008 410 2 225 235 2-s2.0-40449087027 10.1042/BJ20071341 (Pubitemid 351346180)
18. Lin H.-W., Tu Y.-Y., Lin S. Y., Su W.-J., Lin W. L., Lin W. Z., Wu S.-C., Lai Y.-L., Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. The Lancet Oncology 2011 12 9 900 904 2-s2.0-80052380558 10.1016/S1470-2045(11)70165-6
19. Rasmussen C. B., Faber M. T., Jensen A., Høgdall E., Høgdall C., Blaakær J., Kjaer S. K., Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors. Cancer Causes Control 2013 24 7 1459 1464 10.1007/s10552-013-0216-y
20. Skapinyecz J., Smid I., Horváth A., Jeney C., Kardos L., Kovács P., Pelvic inflammatory disease is a risk factor for cervical cancer. European Journal of Gynaecological Oncology 2003 24 401 404 (Pubitemid 37236566)
21. Carvalho J. P., Carvalho F. M., Is Chlamydia-infected tubal fimbria the origin of ovarian cancer? Medical Hypotheses 2008 71 690 693 10.1016/j.mehy.2008.06.028
22. Ness R. B., Goodman M. T., Shen C., Brunham R. C., Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer. Journal of Infectious Diseases 2003 187 7 1147 1152 2-s2.0-0037385131 10.1086/368380 (Pubitemid 36399357)
23. Australian Bureau of Statistics,. May 2013, www.abs.gov.au
24. Verma V., Shen D., Sieving P. C., Chan C.-C., The role of infectious agents in the etiology of ocular adnexal neoplasia. Survey of Ophthalmology 2008 53 4 312 331 2-s2.0-45249115913 10.1016/j.survophthal.2008.04.008 (Pubitemid 351842561)
25. Ruiz A., Reischl U., Swerdlow S. H., Hartke M., Streubel B., Procop G., Tubbs R. R., Cook J. R., Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci. The American Journal of Surgical Pathology 2007 31 5 792 802 2-s2.0-34247641159 10.1097/01.pas.0000249445.28713. 88 (Pubitemid 46684221)